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Abstract
Dosage sensitivity is an important evolutionary force which impacts on gene dispensability and duplicability. The newly
available data on human copy-number variation (CNV) allow an analysis of the most recent and ongoing evolution.
Provided that heterozygous gene deletions and duplications actually change gene dosage, we expect to observe negative
selection against CNVs encompassing dosage sensitive genes. In this study, we make use of several sources of population
genetic data to identify selection on structural variations of dosage sensitive genes. We show that CNVs can directly affect
expression levels of contained genes. We find that genes encoding members of protein complexes exhibit limited
expression variation and overlap significantly with a manually derived set of dosage sensitive genes. We show that
complexes and other dosage sensitive genes are underrepresented in CNV regions, with a particular bias against frequent
variations and duplications. These results suggest that dosage sensitivity is a significant force of negative selection on
regions of copy-number variation.
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Introduction
It has been estimated that at least 2% of the human genome is
affected by structural variations [1], such as inversions, small
insertions/deletions or large copy-number variants (CNVs) [2].
These sometimes large rearrangements can be seen as an
important driving force of genome evolution [3]. As a conse-
quence, theories on gene evolution have to be re-evaluated in the
context of such rapid and widespread large scale variation.
Previous studies have already shown that the locations and
functional annotations of genes in CNV regions are strongly biased
[1,4]. CNVs are found more often in pericentromeric and
subtelomeric regions and they overlap significantly with regions
of segmental duplications. Genes within CNV regions are
frequently involved in sensory perception and immune system
activity, to a lesser extent in cell adhesion and in a number of cases
signal transduction [1]. Furthermore, it has also been observed
that copy-number variability is negatively correlated with protein
interaction network metrics such as connectivity and centrality [5].
Two theories have been postulated to explain this non-random
distribution of CNVs. The mutational hypothesis states that most
CNVs are in effect phenotypically neutral, but are carried by
flanking genomic elements like segmental duplication or ALU
repeats which cause the bias in CNV distribution. The opposing
theory could be called the selection hypothesis, stating that
negative and positive selection shape the distribution of CNVs
through the functional elements they encompass.
Gene duplication and loss are key mechanisms in evolution [6].
Historically, it was assumed in this context that most genes can be
duplicated without substantial negative fitness effects. Similarly,
the established hypothesis explaining gene dominance formulated
by Wright [7] states that dominance is caused by ‘‘bottlenecks’’ in
metabolic pathways and is generally rare [8]. This is in stark
contrast to the observation that at least 20% of the entries in the
OMIM database of human diseases with a Mendelian pattern of
inheritance are described as heterozygous mutations [9]. It has
also been shown that there are distinct differences between genes
as to their duplicability [10,11] and that duplicated genes are in
many cases still under negative selection [12,13]. Birchler et al. [14]
reported widespread dosage compensation upon polyploidization
of several large chromosomal regions in maize. For all these
reasons, it is now widely accepted that some genes are dosage
sensitive.
What are the underlying causes of dosage sensitivity? Papp et al.
[15] postulated that multi-protein complexes need to maintain the
stoichiometry of their subunits to perform their biological function
(the balance hypothesis). A range of experiments lend support to
the balance hypothesis. It has been noted that expression levels of
interacting proteins are highly co-ordinated [16], hinting that
proportionality of subunit abundances is important. In a previous
study, we also reported an enrichment for dominant disease
mutations amongst interacting proteins [17]. Within the concep-
tual framework of the balance hypothesis, this can be explained by
the impact of even small stoichiometric changes (the one mutated
allele) on the function of the entire protein complex. It has also
been argued that tolerance towards polyploidization, compared to
the sometimes severe effects of smaller duplications can be
explained by conservation of stoichiometry [18]. Finally, it has
been noted that highly-interacting proteins in higher organisms
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explained by a bias against duplication acting on multi-protein
complexes.
There have been, however, several conflicting reports.
Deutschbauer et al. [19] performed an exhaustive heterozygous
deletion screen in yeast. They reported only 3% of genes to be
haploinsufficient. While these genes were enriched for members of
protein complexes, their overexpression did not cause a similar
phenotype as their deletion. Subsequently, Sopko et al. [20]
systematically induced gene overexpression for all ORFs in yeast.
The genes found to be toxic when overexpressed did not overlap
with the haploinsufficient genes described by Deutschbauer et al.,
and were not significantly enriched for protein complexes.
These findings point towards a more complex relationship
between haploinsufficiency and duplication sensitivity [21]. A
limited number of enzymes are sensitive to low dosage because
they are the rate limiting factor in a biochemical reaction. A range
of proteins are likely to cause non-physiological binding or even
agglomeration as a result of overexpression, as exemplified by
susceptibility to early-onset Alzheimer’s disease as a result of
duplication of the APP locus [22]. Finally, haploinsufficiency as
well as duplication sensitivity are likely to affect those master-
regulators controlling the balanced expression of a range of other
proteins [23,24]. These proteins are in fact often complexes [25].
The newly developed CORUM database [26] contains
mammalian protein complexes that were manually annotated by
expert curators. It contains a large number of gene regulatory and
transcriptional genes, as listed in Table 1. In this work, we use
gene expression and copy-number variation data to assess the
relationship between protein complexes from CORUM, dosage
sensitivity and recent gene evolution in the human population. We
show that changes in gene copy number have a weak but
measurable effect on gene expression. We find that protein
complex genes are enriched for known dosage sensitive genes and
exhibit substantially lower expressional noise than other genes.
Consequentially, we observe that dosage sensitive genes are
underrepresented in CNV regions.
Methods
The CORUM Database of Mammalian Protein Complexes
The CORUM database [26] is a manually annotated resource,
containing, at the time of writing, 1679 protein complexes from 10
mammalian species, with a strong focus on human. Entries are
based on specific publications, not high-throughput experiments.
Table 1 lists Gene Ontology annotations for which CORUM
deviates significantly from the rest of the genome. CORUM is
enriched for nuclear proteins and contains a large number of
transcriptional regulators. Conversely, extracellular and mem-
brane proteins are underrepresented in the dataset. Figure 1
visually conveys an idea of the size distribution of this network of
human complexes, as well as reflecting its highly interconnected
nature. Relationships for 2080 proteins in 1109 human complexes
were downloaded from the CORUM website [27]. 1975 Human
Genome Nomenclature Committee (HGNC) identifiers [28,29]
for 2028 proteins could be mapped. Genomic coordinates for these
gene identifiers were retrieved from EnsEMBL [30] via Bio-
MART.
Interaction and Complex Data
As an alternative to the manually compiled set of complexes in
CORUM, an independent set of putative complexes was
computationally derived from high-throughput protein interaction
experiments by identifying highly connected clusters of proteins in
an extended network of human protein interactions [31]. Data
from three recent studies [32–34] were merged into one network.
Interaction information was retrieved from IntAct [35,36].
UniProt identifiers were mapped to HGNC identifiers using the
cross references in the full UniProt entries. Clustering analysis was
performed using the Markov clustering tool mcl [37] (parameter
I~3:0). The alternative complex set was composed of all clusters
with more than 3 components, containing 2325 unique genes.
Set of Dosage Sensitive Genes
Dosage sensitive genes were extracted from the annotations of
the Baylor College of Medicine Medical Genetics Laboratory 105k
diagnostic Chromosomal Microarray (version 7) [38]. This post-
natal screening tool comprises a manually compiled set of 146
genes known to be sensitive to chromosomal imbalances [39].
A separate set of genes overexpressed in cancer tissue was also
used [40]. The dataset contains 2362 genes which are at least 4-
fold overexpressed in brain (astrocytoma and glioblastoma), breast,
colon, endometrium, kidney, liver, lung, ovary, prostate, skin, and
thyroid cancers compared to healthy tissue of the same type.
Expression Profiles
Gene expression data were acquired from two independent
sources: Expression data for 44760 probes applied to samples from
79 different tissue types were provided by GNF SymAtlas [41,42].
Population-independently normalised expression data for 47293
probes applied to samples from lymphoblast cell lines of 270
HapMap individuals were provided by Stranger et al. [43,44].
Probe identifiers were mapped to HGNC gene names through
EnsEMBL BioMart. Probes which could not be mapped to a gene
Table 1. Composition of the CORUM database.
GO-Slim Term
Number of CORUM
genes P-Value
protein binding 1348 1:78:10{210
nucleus 1058 3:73:10{207
macromolecule metabolic process 1321 1:59:10{205
nucleobase, nucleoside, nucleotide
and nucleic acid metabolic process
852 4:52:10{148
nucleic acid binding 708 5:73:10{86
cytoplasm 933 2:72:10{62
regulation of biological process 722 1:24:10{51
chromosome 168 7:95:10{46
structural molecule activity 227 5:51:10{38
transcription regulator activity 301 1:63:10{30
biosynthetic process 279 5:37:10{26
helicase activity 53 1:14:10{15
cell death 146 1:12:10{12
protein transporter activity 45 3:32:10{11
response to stimulus 378 3:42:10{08
translation regulator activity 34 2:29:10{06
cell differentiation 232 1:54:10{05
extracellular region 77 1:94:10{06
membrane 532 3:35:10{15
Underrepresented terms are set in bold font.
doi:10.1371/journal.pone.0009474.t001
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contained expression data for 17122 genes (HapMap set) and
15012 genes (tissue set), respectively. Due to technical limitations
of the Illumina WG6 expression arrays used by Stranger et al.,
there is a correlation between detectable expression variation and
total expression strength (Figure 2A) for genes with low overall
expression. Therefore, 6440 genes with an absolute population
standard deviation ƒ7 were removed from the dataset.
Correlation Computation
As a measure of correlation between expression levels of two
genes in different tissues/individuals, the Pearson product-moment
correlation coefficient was employed. For two vectors x and y
representing genes with n expression levels, the correlation rxy is
given by
rxy~
Pn
i~1 (xi{x)(yi{y)
(n{1)sxsy
ð1Þ
where x and y are the means and sx and sy are the standard
deviations of x and y, respectively. For complexes with more than
2 components, correlations for all n(n{1)=2 combinations of gene
pairs were averaged.
Copy-Number Variations
Chromosomal locations of variations relative to the NCBI36
human genome assembly were downloaded from the Database of
Genomic Variants (DGV) [45,46]. This data also contains
information on number of individuals and gain/loss annotation
per CNV. CNV locations and WGTP array hybridisation values
for each HapMap individual were provided by Redon et al.
[47,48].
Segmental Duplications
Segmental duplications of §90% sequence identity and §1
kilobase length were provided by the segmental duplication
database [49,50].
Figure 1. A network representation of the CORUM database. Nodes represent complexes and are ordered by number of unique components
(shown as number next to groups). Edges denote shared components between complexes. The number of shared components is reflected in the
colour (from yellow (few) to red (many) shared components) as well as in the line width. The large, highly overlapping complexes in the first row are
mainly modules of the ribosome (6 out of 12) and spliceosome (3 out of 12). Other large complexes include RNA polymerase, respiratory chain
complex and the proteasome. The group of complexes with only 1 member are homo-dimers.
doi:10.1371/journal.pone.0009474.g001
CNVs and Dosage Sensitivity
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Gene Ontology (GO) annotations from the GOA project [51]
were mapped to HGNC identifiers through UniProt accessions.
To reduce complexity, GO terms were integrated into GO-slim
categories, as defined by the GOA project [52].
Analysis of Selection Pressure
dN/dS values for human genes relative to mouse orthologs were
acquired from EnsEmbl via BioMart. Only genes with a single
unique ortholog in mouse were used in the analyses.
Identification of Paralogs
In-species paralogs for 10755 HGNC gene identifiers were
downloaded from EnsEmbl Compara via BioMart. The paralog
prediction uses automatically generated maximum-likelihood
phylogenetic trees. Details can be found at the EnsEMBL compara
website.
P-Values
Statistical significance of overlaps between gene sets was
computed with Fisher’s exact test (FET). The Mann-Whitney-U
test (MWU) was employed to determine significance of differences
between two distributions. In cases of multiple testing, Bonferroni
correction was applied. All calculations were performed in R [53].
Significance of differences in dN/dS ratios was calculated by
random resampling: For the null hypothesis, 1000 sets of genes
with identical size as the test set were each created by randomly
drawing without replacement from the complete gene set. P-
Values were calculated as the probability of observing a result at
least as extreme, given the normally distributed null model derived
from the resampling.
Results
Effects of CNVs on Gene Expression
Association studies [43] have shown both cis and trans effects of
copy-number variations (CNVs) on genes. However, there are few
reports of a direct quantitative effect on expression levels for genes
inside a specific CNV [54]. We therefore focused our attention on
the relationship between copy-number variations and gene dosage.
We combined gene expression data derived from lymphoblast cell
lines of 270 HapMap individuals [43] with the CNV dataset of
Redon et al. [47] on the same individuals.
We find that duplications and deletions have distinguishable
profiles of expression ratios. The expression ratio is defined as
the average expression of a gene in individuals with a CNV
phenotype, divided by the average expression in wild-type
individuals. Assuming a simple linear relationship between copy-
number and expression level, one would expect a distribution with
peaks at 0:5, 1 and 1:5, corresponding to a heterozygous deletion,
balanced expression and heterozygous duplication, respectively.
The observed distribution shown in Figure 3 reflects a more
complex relationship.
The magnitude of the expression difference between CNV and
wild type individuals is smaller and more continuous than
expected. However, the location shift between the two distribu-
tions is highly significant (MWU: P~1:22:10{11). This indicates
that deletions reduce gene expression, while duplications tend to
increase expression. As mentioned in the Methods, sensitivity and
Figure 2. Coefficients of gene expression variation (CV), defined as standard deviation normalised to expression mean, vary for
CORUM and non-CORUM genes. A) Effects of resolution and dynamic range of expression arrays on CVs. The measurable variation in gene
expression is limited by the sensitivity of the employed array technology. Genes which are expressed at extremely low levels, or not expressed at all,
cluster in the low expression/low CV region. Shown in grey are genes which were excluded from further calculations (standard deviation ƒ7). B)
CORUM genes have significantly smaller CVs than non-CORUM genes. Outliers beyond 1:4 are not shown. C) Large CORUM complexes exhibit lower
average CVs of their members.
doi:10.1371/journal.pone.0009474.g002
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the observed noise, but we did not find a correlation between
absolute gene expression level and ratio of expression difference
for genes overlapping CNV regions (data not shown).
The expression ratio distribution reflects a summary over a wide
range of individuals. To elucidate the effects of CNVs on gene
expression on a per-individual basis, we plotted the logarithm of
hybridisation strength on the genomic hybridization arrays relative
to the reference individual (log
H
2 ) against the logarithm of
expression, relative to the reference individual (log
E
2 ). We find
several examples of a linear relationship between copy-number
and gene expression. As a positive control, we compared two X-
chromosomal genes, one being inactivated (L1CAM, Figure 4A),
the other being known to escape X-inactivation (UTX, Figure 4B).
The latter exhibits a marked increase in expression in female
individuals relative to the (male) reference individual. In contrast,
L1CAM maintains equivalent expression levels due to inactivation
of one gene copy.
Figures 4C and 4D show two examples of copy-number varied
genes with induced dosage effects. Deletions and duplications have
clearly distinguishable expression levels. Notably, though, the
expression ratios of the deletion/duplication individuals overlap
with the expression ratios of wild-type individuals. In other words,
CNVs only partly account for the differences in expression
between individuals, while a large portion of the variance must
stem from other sources.
Furthermore, several individuals were not called as CNVs,
despite similar logH
2 and logE
2 ratios in the analysed region as the
identified CNV individuals. These putative false negatives will
reduce the magnitude of expression ratios between CNV and wild-
type individuals. Summarising these individual effects leads to the
conclusion that duplications and deletions affect gene dosage,
although they are not usually the primary sources of expression
differences between individuals.
Limited Expressional Noise of Protein-Complex Genes
It has previously been reported that expression levels of proteins
within a complex are significantly more correlated across tissue
types than would be expected by chance [16,55]. Using both the
expression from HapMap individuals mentioned above as well as a
tissue-specific gene expression dataset, we verify that members of
complexes from the CORUM database exhibit increased
expression correlation (Figure 5).
In addition to that, the HapMap expression data allow us to
perform a direct comparison of expression levels between
individuals. We calculated coefficients of variation (CV), defined
as the average variation in absolute expression levels per gene,
normalised to the mean absolute expression level, see Figure 2.
The CVs are significantly smaller for CORUM genes than for the
rest of the genome (MWU: P~2:67:10{10). Interestingly, the
average CV of genes within one complex decreases with the size of
the complex, as shown in Figure 2C. We asserted that this effect is
Figure 3. Difference between deletion (white) and duplication (black) variations in HapMap individuals. The histograms show the ratio
of average expression levels between individuals with and without the CNV for all genes inside a CNV region. The shift between the two distributions
is significantly larger than would be expected by chance (MWU: P~1:22:10{11).
doi:10.1371/journal.pone.0009474.g003
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with complexes of size §10 and size v10 and comparing the
distribution of CVs, we see that small complexes possess higher
CVs (MWU: Pv2:2:10{16). These results indicate that members
of protein complexes are not just more likely to maintain relative
expression levels between tissue types, but they are also more
restricted as to their expression variation between individuals
within the same tissue.
Axelsen et al. [40] compiled a list of 2362 genes which are
overexpressed in various cancer tissues (see Methods). We
speculated that these cancer related genes will be enriched for
dosage sensitive genes whose overexpression in turn contributes to
the disease phenotype. Consequentially, we find that CORUM is
enriched for these cancer related genes (356 genes, FET:
P~6:56:10{13). The fact that the tight regulation of expression
of CORUM genes is disturbed in cancer tissue provides an
interesting link between cancer, protein complexes and dosage
sensitivity.
CORUM is a manually curated data source and thus prone to
ascertainment bias. To ensure that these results are not biased by
the composition of CORUM, we generated a separate dataset of
putative protein complexes extracted from several high-through-
put protein interaction detection experiments (see Methods). The
clusters represent an alternative set of ‘‘complexes’’ composed of
2325 proteins, 505 of which are also contained in CORUM. The
CV distribution difference between these highly interacting
Figure 4. Ratio of WGTP array hybridisation intensity over relative expression level for four example genes. A) L1CAM and B) UTX. The
increase in expression as a result of the copy-number increase in females is clearly visible for UTX which is known to escape X-inactivation. C) and D)
Examples of autosomal genes with common CNV polymorphisms. Red crosses denote individuals in which a deletion phenotype has been called by
Redon et al., red triangles denote duplications. The plot highlights several potential false negatives with similar expression and hybridisation strength
as the called deletions/duplications. Non-CNV related expression variation is substantial.
doi:10.1371/journal.pone.0009474.g004
CNVs and Dosage Sensitivity
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CVs (P~7:0:10{3). This suggests that highly connected proteins
in general avoid imbalances in protein expression.
Dosage Sensitive Genes and CNVs
We have shown above that protein complexes are under
constraint to maintain their relative expression levels and exhibit
limited expression variability between individuals. For our further
analysis of dosage sensitivity, we also used an independently
assembled set of 146 genes with known dosage-related disease
phenotypes (see Methods). There is a significant overlap between
CORUM and this set of dosage sensitive genes (32 genes, FET:
P~1:2:10{5), further supporting the link between dosage
sensitivity and protein complexes. We henceforth use these two
datasets as examples of dosage sensitivity.
As previously stated, we found that CNVs can affect the
expression levels of genes they contain. We therefore hypothesised
that a CNV that encompasses a gene which is part of a protein
complex will be more likely to have a negative effect on fitness. As
most available CNV data were derived from healthy individuals,
we expect that genes encoding protein complexes will be
underrepresented in CNV regions.
Out of 18534 protein coding genes for which both genomic
locations and a unique gene name could be retrieved, 2311 genes
are fully inside a CNV region. From 1975 proteins in the
CORUM database, only 165 are found in a CNV region,
significantly fewer than one would expect by chance (FET:
P~3:5:10{10). The set of automatically clustered complexes were
also underrepresented in CNV regions (256 out of 2325 genes,
P~0:012). Lastly, both the set of 146 dosage sensitive genes (8
genes overlap, P~4:7:10{3) as well as the 2362 genes overex-
pressed in cancer (246 genes overlap, P~5:82:10{4) are unlikely
to be contained in CNV regions.
Nguyen et al. as well as Cooper et al. reported a highly significant
depletion of genes with the Gene Ontology (GO) category
‘‘binding’’ within CNV regions, but they do not comment further
on this fact. We verified independently that ‘‘binding’’ is the
second most underrepresented GO category after ‘‘intracellular’’
amongst genes in CNV regions. This lends further support to the
hypothesis that dosage sensitivity due to protein complex
membership has an influence of the composition of CNV regions.
We speculated that a negative fitness effect due to a copy-
number variation will increase the likelihood of subsequent
removal of that CNV from the gene pool. The CNVs that
contain CORUM genes occur in significantly fewer individuals
(MWU: P~1:6:10{4) than non-CORUM genes, indicating that
purifying selection has acted on some of the genes.
We also tested whether CORUM genes are underrepresented in
gains compared to losses. Out of the 167 CORUM genes that
overlap a CNV, 18:5% occur in a gain, compared to 29:8% of
non-CORUM genes. This significant difference in ratios (FET:
P~9:6:10{4) suggests that amongst copy-number varied genes,
there is indeed a bias against duplications for genes in protein
complexes, supporting the notion that stoichiometric imbalance
has a negative effect on protein complexes.
Compositional Bias of Copy-Number Varied Genes
Various compositional biases on genes in CNV regions have
been described [1,4]. Most notably, it has been reported that genes
within CNV regions exhibit higher dN/dS than the rest of the
genome. Is the observed low frequency of CORUM and other
dosage sensitive genes in CNV regions merely a result of a bias
against faster evolving genes? We verified that dN/dS ratios of
genes within CNV regions were elevated compared to their mouse
orthologs (Median: 0:131, P-Value by resampling: P~3:2:10{7).
CORUM genes exhibit lower than expected dN/dS (Median:
0:070, Pv10{40). In contrast to non-complex genes, there is no
significant difference in dN/dS between CORUM genes that
overlap CNVs and those that do not. We therefore tested if there is
Figure 5. Distribution of average Pearson correlation coefficients between all members of known proteins complexes as defined in
CORUM (black), and randomly sampled proteins (white, N=10). Expression data was taken from the Human Gene Expression Atlas (see
Methods).
doi:10.1371/journal.pone.0009474.g005
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and CNV overlap.
Like CORUM genes, the automatically clustered complexes
also exhibited low dN/dS (Median 0.08, P~1:9:10{30). It has
been argued that proteins with obligate interactions are under
stronger selective pressure [56], which could explain the low dN/
dS in both CORUM and the automatically clustered complexes.
Interestingly, Cooper et al. showed that CNVs and segmental
duplications (SDs) are of fundamentally similar nature and
frequently overlap. We thus hypothesised that the reduction in
negative selection within CNVs is related to the higher copy
number of some genes which have been recently duplicated in a
fixed SD. If we split the genes in CNV regions into those that
overlap a SD and those that do not, we see that dN/dS ratios are
highly significantly elevated in the genes that overlap SDs (MWU:
Pv2:2:10{16), but not in the group outside SDs (P~0:017).
Subsequently, we analysed the distribution of numbers of
paralogs for human genes. We found that genes in CNV regions
have significantly more paralogs than would be expected by
chance (MWU, P~1:45:10{9),whereas genes from CORUM
have significantly fewer (Pv2:2:10{16). As with the evolutionary
rate, the increase in numbers of paralogs is largely driven by CNVs
that overlap SDs. Removing all genes inside SDs reduced the
number of paralogs substantially (P-value reduced to from
1:45:10{9 to 0:0033). Conversely, the genes that are in both
CNVs and SDs have significantly more paralogs than genes only
found in CNV regions (P~4:3:10{11). We conclude that the
increase in dN/dS in CNV regions is driven by an increase in gene
copy number and thus does not explain the underrepresentation of
dosage sensitive genes in CNV regions.
If SDs are largely responsible for the increased dN/dS within
CNVs and the increase in number of paralogs, can we still detect
the underrepresentation of CORUM genes in CNVs that do not
overlap a SD? We recalculated the contingency tables after
removing all genes that overlap a SD. CORUM genes are still
significantly underrepresented (P~3:3:10{4), indicating that
negative selective pressure not only affects regions of segmental
duplication but also other types of CNVs.
Discussion
Protein Complexes Are Sensitive to Alterations in Gene
Expression
Correlated gene expression of interacting proteins is a well
known phenomenon, to the extent that correlation analysis is used
to validate high-throughput protein interaction experiments [55].
Usually, expression data is gathered under diverse physiological
conditions, e.g. at different stages of cell cycle. In our analysis, we
have compared data from 79 different human tissue types. As
expected, we observe strong correlation between the changes in
gene expression for members of the same protein complex in
different tissues. This observation hints at the importance of tightly
regulated gene expression for the correct functioning of protein
complexes.
However, it does not directly verify if the stoichiometry of
complexes is under the same strong regulation. We therefore
measured the variation in expression levels for interacting proteins
in different HapMap individuals. Expressional noise of protein
complexes has been analysed in yeast and fruit-fly [57], but the
HapMap gene expression data allow the first systematic evaluation
of protein complex expression in human. We find that genes in
CORUM exhibit significantly smaller variation in expression than
the rest of the genome. This is direct evidence that expression of
complex genes is under tighter regulation than the rest of the
genome. Furthermore, we see that genes in large complexes
maintain particularly low expression variation. While we cannot
rule out that this observation is due to functional constraints on the
particular complexes, it does suggest that sensitivity to expressional
noise is related to the number of subunits a complex maintains.
When we analysed the composition of genes in CNV regions,
we made the curious observation that the small number of
CORUM genes that overlap a CNV (165 genes in total) are biased
towards deletions rather than duplications. If we assume that
negative selection is acting on CNVs, the intuitive biological
explanation for this phenomenon would be that CORUM genes
are at least as sensitive to duplication than deletion, which in turn
supports the concept that members of protein complexes are
sensitive not just to under- but also to overexpression.
We made another observation that support this hypothesis.
When comparing a manually curated set of dosage sensitive genes
derived from the scientific literature, we found that a significantly
larger than expected proportion of these genes were members of a
protein complex as defined by the CORUM database. Taken
together, these findings clearly indicate that stoichiometric
fluctuations negatively affect protein complexes.
CNVs Affect Expression Levels of Contained Genes
A key proposition that underpins our understanding of dosage
sensitivity is that duplication or deletion of the genomic region
containing a gene will result in a significant up- or downregulation
of expression of the gene [58]. There have been previous reports of
widespread expressional silencing of chromosomal amplifications
[54]. In contrast, we observed lower average gene expression in
deletion CNVs compared to duplication CNVs (Figure 3). It has to
be noted, though, that these differences in expression are small for
the majority of genes within a CNV. Furthermore, there are
numerous cases where deletions seemingly result in increased
expression and vice versa. Figures 4C and 4D exemplify how noisy
the expression data for a gene can be, despite a visible expression
difference between deletion and duplication genotypes. Sensitivity
to detect expression differences at low concentration is not the
main source of this variability in gene expression. Rather, we
suspect there to be inherent fluctuations between the different cell
lines used in the analysis [59]. Expressional noise alone does not
explain that some CNVs seem not to affect gene expression at all.
Rather, the inaccurate prediction of start and end coordinates of
CNVs is likely to be largely responsible for the lack of correlation
between CNVs and gene expression. Individuals with a CNV
genotype falsely labelled as unaffected, or a gene erroneously
placed inside a CNV, will skew the distribution of expression
ratios.
We speculate, however, that there could also be a physiological
explanation for the unexpectedly low change in gene expression
upon copy-number variation. It is conceivable that the cell
attempts to compensate changes in copy number on gene
expression by e.g. increasing or decreasing transcription or
modulating mRNA degradation. Such autosomal dosage com-
pensation has been first observed in maize and Drosophila [60–62]
and a general mechanism for dosage regulation has been proposed
[63]. According to this theory, dosage balance is achieved through
a network of regulatory genes which themselves are therefore
dosage sensitive. The enrichment of CORUM for regulatory and
transcription related functions might thus explain its sensitivity to
copy-number variation and the low effect of CNVs on gene
expression at the same time. With the arrival of new CNV datasets
featuring improved breakpoint accuracy, it should become
possible to better distinguish between false positive predictions
and genes that are actually subject to dosage compensation.
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of dosage compensation of copy-number varied genes.
CNVs as the Source of Recent Duplications
It has been noted [4] that genes within CNV regions exhibit
higher than expected dN/dS ratios, suggesting a relaxation of
selective pressure. On the contrary, complex genes, dosage
sensitive genes and highly connected genes in general, show very
low dN/dS ratios, irrespective of whether they overlap CNVs or
not. Stronger selective constraints in highly connected proteins
have previously been attributed to functional constraints on the
protein surface in order to maintain multiple binding sites [56].
Interestingly, we also show that genes in CNV regions have
significantly more paralogs than expected by chance, while genes
in protein complexes possess, on average, fewer paralogs [10].
This suggests that CNV regions have been hot-spots of large scale
variation for a prolonged period of time, as it has also been shown
that gene-rich CNV regions correspond well with regions of
segmental duplications [1]. In fact, we found that those CNV
regions that overlap segmental duplications are primarily (though
not exclusively) responsible for the high number of paralogs.
Conversely, the reason for the increase in dN/dS in many genes
within CNV regions could be attributed to their higher number of
paralogous sequences. In fact, genes in CNVs overlapping
segmental duplications are again primarily, but not exclusively,
responsible for the elevated dN/dS ratios. These observations
underline that CNV regions are a frequent source of gene
duplicates which occasionally get fixed over the course of evolution
and thus drive evolution of some gene families.
Dosage Sensitivity and Negative Selection on CNVs
We observed that CNV regions are less likely to contain genes
encoding protein complexes, as well as other dosage sensitive
genes. Furthermore, CNVs which occur in multiple individuals
and can thus be assumed to be older than unique CNVs are
particularly depleted of CORUM genes. Hence, it appears that
pressures on correct dosage limit the set of genes which can sustain
variation in copy-number, even though the effect of CNVs on gene
expression is not straightforward.
Dang et al. [64] reported that haploinsufficient genes are
seldomly found between two regions of segmental duplication.
Our results shed new light on this finding: It seems that dosage
sensitive genes in general are biased against regions in which they
are prone to suffer from copy-number variation. Segmental
duplications are the most common source of such rearrangements,
however we show that other CNVs not related to segmental
duplications are also depleted of dosage sensitive genes. This
indicates that negative selection is acting at the level of CNVs. Our
findings offer a partial but consistent explanation for the biased
composition of CNV regions. In addition to that, the correlation
between dosage sensitivity and protein complex membership
provides a convenient way to predict which genes are likely to be
important in diseases which involve genomic rearrangements. The
enrichment of CORUM for genes upregulated in cancer clearly
hints towards this possibility. Future investigations should focus on
the involvement of CNVs of putative dosage sensitive genes in
cancer and complex diseases.
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